This HTML5 document contains 151 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33214444
rdf:type
wikibase:Item
schema:description
2005 nî lūn-bûn научна статия vitenskapelig artikkel mokslinis straipsnis vědecký článek 2005年論文 2005年论文 bài báo khoa học bilimsel makale article scientifique (publié 2005) ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2005 مقالهٔ علمی vetenskaplig artikel 2005 թուականի Մայիսին հրատարակուած գիտական յօդուած artikulong pang-agham vitskapeleg artikkel 2005 թվականի մայիսին հրատարակված գիտական հոդված наукова стаття, опублікована в травні 2005 artigo científico (publicado na 2005) мақолаи илмӣ artigo científico (publicado na 2005) 2005年論文 artículo científico publicado en 2005 научни чланак научная статья 2005年論文 мақолаи илмӣ 2005年论文 videnskabelig artikel (udgivet 2005) wetenschappelijk artikel מאמר מדעי articol științific 2005年論文 article científic научни чланак scienca artikolo article scientific 2005년 논문 سائنسی مضمون scientific article naučni članak tieteellinen artikkeli artykuł naukowy مقالة علمية wissenschaftlicher Artikel სამეცნიერო სტატია 2005年论文 tudományos cikk vedecký článok 2005年论文 artigo científico 2005年の論文 2005年论文 artikull shkencor 2005年論文 teaduslik artikkel บทความทางวิทยาศาสตร์ articolo scientifico 2005年论文 επιστημονικό άρθρο
p:P577
wds:Q33214444-3747373E-DD2E-4C38-92F8-4FD61C9787FB
wdt:P577
2005-05-01T00:00:00Z
p:P407
wds:Q33214444-DFDDAC9E-3743-42FD-84EB-3AD89E652571
wdt:P407
wd:Q1860
p:P2888
wds:Q33214444-59412FEF-76F7-4884-B42B-3FE37E7DDA0E
wdt:P2888
n11:sj.bjc.6602576
p:P2860
wds:Q33214444-7EC6C517-806C-41AC-AF95-6C9B02147895 wds:Q33214444-C8A78F37-948F-49DB-9734-7B97E614837A wds:Q33214444-D1499F41-8E04-476B-9BDA-8675BF6A0C08 wds:Q33214444-E1A7EE58-A522-4E6D-A6A2-C38217F2BA6A wds:Q33214444-21964279-DFB3-4D02-A0E4-5FC5520B6E54 wds:Q33214444-2EF3C7FE-DDEC-445E-9E2F-925BA33B3544 wds:Q33214444-2F33C725-3CA2-4053-830C-8321AC4B3CEC wds:Q33214444-3396CB24-A0B1-4A69-811E-4A983C0A3C39 wds:Q33214444-3DCE6346-2EBC-4AE8-B9CC-659B8DFEA11B wds:Q33214444-3E5F22FE-972B-4CFC-B5CB-1DF4B6DA3F4F wds:Q33214444-3F1D784D-A659-4051-84B6-128BBDCB9F19 wds:Q33214444-4D566B4F-54AA-4EE9-85E8-4A10BBD18B90 wds:Q33214444-678AD4F3-79FE-40F5-855A-D5C70B820E87 wds:Q33214444-6A6DE126-911F-4700-AF67-A9BF64FEE447
wdt:P2860
wd:Q34063503 wd:Q33338191 wd:Q33493886 wd:Q50163824 wd:Q33961881 wd:Q42555316 wd:Q35363829 wd:Q33336807 wd:Q29547565 wd:Q33503141 wd:Q72398245 wd:Q61868335 wd:Q33949931 wd:Q78690345
p:P2093
wds:Q33214444-87FEB1F4-A255-4EB8-8112-1B001C2967A0 wds:Q33214444-47249566-7544-47B0-A196-16B5D869BC9E wds:Q33214444-0BC95307-F4C3-4FAB-BA3F-9491A50271AA wds:Q33214444-1D2C2306-1816-4BC5-B55A-899E07DE758F wds:Q33214444-F7D7B791-5937-4A99-8EA5-1A77284ED88E wds:Q33214444-A63BF40F-215A-40E9-8C10-B287B62CC2F1 wds:Q33214444-AD7ADDA1-0D31-495C-8A3F-015E1DC064B9 wds:Q33214444-A197F4DA-CF6D-4847-8F74-D0FC3492DF4D
wdt:P2093
Rao S Daniel F Norman AR Hill ME Ross PJ Hawkins RE Smith D Oates J
rdfs:label
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
skos:prefLabel
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
schema:name
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
p:P50
wds:Q33214444-E1ECA256-F749-4483-9C39-42874FADB7C2
wdt:P50
wd:Q38803238
p:P1476
wds:Q33214444-BCE03566-C1C2-46B3-8714-85601E798048
wdt:P1476
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
p:P304
wds:Q33214444-9BF410F1-56AA-43E3-B9FB-E19A59951269
wdt:P304
1650-1654
p:P31
wds:Q33214444-7BF16DD6-C398-4CC2-A870-3755CDEE06E9
wdt:P31
wd:Q13442814
p:P921
wds:Q33214444-5930A568-5025-4CF6-9EED-3A65B2F0B5A8 wds:Q33214444-D5A9A102-F09B-41D4-947E-3F20BAA7FA29
wdt:P921
wd:Q412415 wd:Q418817
p:P698
wds:Q33214444-D40F974E-6938-4AC4-B2A4-6B690DA271A6
wdtn:P698
n13:15856037
wdt:P698
15856037
p:P1433
wds:Q33214444-FCF2B64F-5431-4599-A318-E8E196BD0CD1
wdt:P1433
wd:Q326309
p:P433
wds:Q33214444-D021DC78-106B-4E70-AE3A-2ED4BEE5D5A4
p:P478
wds:Q33214444-D2915D36-6DA8-4A07-B8D9-655968D7CB8C
wdt:P433
9
wdt:P478
92
p:P356
wds:Q33214444-799A9BB3-DE42-4A9F-B62B-10B28937E158
wdtn:P356
n9:SJ.BJC.6602576
wdt:P356
10.1038/SJ.BJC.6602576
p:P5875
wds:Q33214444-C663FCEC-008B-497A-82DA-037849854B63
wdt:P5875
7882086
p:P6179
wds:Q33214444-49077877-EFC4-4C8E-9B24-E42AEF3229A0
wdt:P6179
1052616134
p:P932
wds:Q33214444-7A248E65-88CA-48F5-AC2C-D9202A35028F
wdt:P932
2362051